Clinical Trials Logo

Filter by:
NCT ID: NCT06410144 Not yet recruiting - Clinical trials for Chronic Kidney Diseases

Outcomes of a Palliative Care Intervention to Improve Kidney Therapy Decision-Making for Older People With Advanced Chronic Kidney Disease (CKD)

CKD-EDU
Start date: August 2024
Phase: N/A
Study type: Interventional

The investigators are conducting a study to see if an educational program called Chronic Kidney Disease-Education (CKD-EDU) can help make better kidney therapy decisions and improve the well-being of older adults. Investigators are also investigating if this program can reduce the number of hospital or emergency room visits in the first 6 months of the study, as well as potentially improve end-of-life care for older adults. Half of the participants will receive the CKD-EDU intervention, while the other half will continue with their usual nephrology care. Investigators will compare the two groups to see if participants who received the intervention feel better prepared about their kidney therapy decisions, experience improved end-of-life care, and have fewer emergency room visits, hospital admissions, Participants in the intervention group will get information about kidney disease treatment and meet with a palliative care specialist who's an expert in decision-making.

NCT ID: NCT06409949 Recruiting - Clinical trials for Peripheral Arterial Disease

MitoQ Treatment of Claudication: Myofiber and Micro-vessel Pathology

Start date: June 1, 2023
Phase: N/A
Study type: Interventional

In our research, we are delving into whether taking MitoQ for six months can improve the symptoms and function of people diagnosed with peripheral artery disease, especially those who suffer from leg pain while walking, known as intermittent claudication. We will be checking if MitoQ helps people with claudication walk better, be more active every day, feel better about their lives, and if it enhances the health of their leg muscles.

NCT ID: NCT06409559 Recruiting - Acetabular Fracture Clinical Trials

Rim Plate to Buttress Plate for Posterior Wall Acetabular Fractures With and Without Inter-fragmentary Screws

Start date: August 1, 2023
Phase: N/A
Study type: Interventional

The hypothesis of this study is that the Rim Plate method utilizing interfragmentary screws placed through the plate will result in superior fixation, a lower rate of loss of reduction of the fracture fragment, better anatomic healing of the articular (joint) surface, a decreased rate of early post-traumatic arthritic changes of the joint (cartilage) surface, and improved functional outcomes.

NCT ID: NCT06409390 Recruiting - Clinical trials for Metastatic Breast Cancer

Sequential Therapies Modeled on Evolutionary Dynamics for Breast Cancer

Start date: April 26, 2024
Phase: Early Phase 1
Study type: Interventional

The purpose of the study is to test a treatment strategy with currently approved drugs to see if it is practical to administer the available drugs in a new way that researchers hope could be more effective in treating metastatic breast cancer.

NCT ID: NCT06409195 Recruiting - Clinical trials for Non-Melanoma Skin Cancers

A Trial to Study the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Seborrheic Keratoses and Non-Melanoma Skin Cancers

Start date: March 25, 2024
Phase: Phase 2
Study type: Interventional

Open-Label study evaluating safety and efficacy of SM-020 Gel 1.0% in subjects with Seborrheic Keratoses and Non-Melanoma Skin Cancers (i.e. Basal Cell Carcinoma and Squamous Cell Carcinoma In Situ). Subjects will be enrolled into 1 of 5 cohorts. Each cohort will enroll approximately 5-10 subjects with at least 1 eligible lesion to be treated. A maximum of 5 lesions may be enrolled per subject. Treatment for all subjects and all lesions will be twice daily for approximately 28 days. Post treatment, residual lesions may be excised per standard of care for histological evaluation. The duration of the study is estimated to be approximately up to 12 weeks from the beginning of the Screening period until the last subject's last visit.

NCT ID: NCT06409156 Not yet recruiting - Clinical trials for Open Abdominal Surgery

EOIFP Block Versus OSTAP Block for Upper Abdominal Surgery

Start date: July 1, 2024
Phase: Early Phase 1
Study type: Interventional

The investigators propose a single-center, assessor blinded, randomized control trial to compare the efficacy of external oblique fascial plane (EOIFP) block versus Oblique Subcostal Transversus Abdominis Plane (OSTAP) block for patients undergoing open upper abdominal surgery at Cleveland Clinic Main Campus.

NCT ID: NCT06409130 Recruiting - Clinical trials for Alcohol-related Liver Disease

Effects of NNC0194-0499, Cagrilintide, and Semaglutide Alone or in Combinations on Liver Damage and Alcohol Use in People With Alcohol-related Liver Disease

Start date: May 20, 2024
Phase: Phase 2
Study type: Interventional

The study will look at the effects of NNC0194-0499, cagrilintide and semaglutide, on liver damage and alcohol use in participants with alcoholic liver disease. Participants will get NNC0194-0499, semaglutide, cagrilintide or "dummy" medicine in different treatment combinations. Which treatment participants get is decided by chance. The study will last for about 39 weeks.

NCT ID: NCT06409091 Completed - Hernia, Ventral Clinical Trials

Short Term Outcomes of Heavy-weight Versus Medium-weight Synthetic Mesh

Start date: January 1, 2012
Phase:
Study type: Observational

This study compares short term outcomes of patients undergoing a hernia repair with heavy weight mesh vs medium weight mesh in clean-contaminated and contaminated cases.

NCT ID: NCT06409065 Recruiting - Cancer Clinical Trials

Psycho-Spiritual Management for Patients With Advanced Cancer and Their Family Caregivers

Start date: January 9, 2024
Phase: N/A
Study type: Interventional

The goal of this behavioral research study is to learn about the effects of two different supportive care programs on patients' and their family caregivers' psychological wellbeing and overall quality of life.

NCT ID: NCT06409052 Not yet recruiting - Endometrial Cancer Clinical Trials

Endometrial Cancer, Risk Factors and Prevention Strategies: Perspectives of Patients and At-Risk Women

Start date: August 30, 2024
Phase:
Study type: Observational

To learn more about women's attitudes toward and knowledge about endometrial cancer and options that might decrease the risk of developing